Latest Inhalable insulin Stories
PARIS and VALENCIA, Calif., Aug.
LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
NEW YORK, July 3, 2014 /PRNewswire/ -- MannKind Corporation (NASDAQ: MNKD) is a biopharmaceutical company focused on the discovery and development of therapeutic products for diseases such as
This week, the US Food and Drug Administration approved the rapid-acting Afrezza Inhalation Powder system to improve glycemic control in adults with diabetes mellitus, or Type I diabetes.
NEW YORK, May 14, 2014 /PRNewswire/ -- MannKind Corporation (NASDAQ: MNKD) In the U.S. alone, roughly 1 of 12 people are managing diabetes.
ChinaMarketResearchReports.com adds Latest Report on “China Insulin Industry Report, 2012-2015” to its store. Dallas, TX (PRWEB) October 05, 2013
MannKind Corp. announced on Wednesday its inhaled insulin device was shown to be more effective than injected and oral treatments in two late-stage clinical trials.
- totally perplexed and mixed up.